All leading OEMs are looking at manufacturing out of India. There are huge distribution networks that are looking at outsourcing manufacturing from India. These people are looking at Polymed - as a leading manufacturer of a basket of products
OEM vertical is our focus area. We plan to scale up this vertical significantly. As mentioned before there is interest being shown by lot of global players. Let us see what emerges.
Donald paaji will not Polymedicure ‘brand’ be diluted if they pursue OEM deals in a significant way ? Or are products ( OEM supplies) retailed under Poly medicure brand presently and will be in future ?
For the size of a company like Poly Medicure today, its no wonder that its own brand sales are miniscule - as its spending power for creating ist own branding in global markets.
The only way it can scale will be through big-time volumes that are with the largest OEMs of Medical devices - who own brand and mindspace of doctors/hospitals. All global OEMs are trying to rationalise their cost structures by outsourcing manfacturing. So its a win-win relationship that can be created.
Poly Medicure is sure to strike a deal sooner than later with OEMs/large distributors - due to comparable quality with superior cost-structures vs the leading players. They also have the requisite USFDA approved facilities.
The only way it can scale will be through big-time volumes that are with the largest OEMs of Medical devices - who own brand and mindspace of doctors/hospitals
Completely with you… Its too difficult to break into the big league (B. Braun, BD etc)…
Hope they don’t dilute their brand by focusing too much on OEMs… Just smartly scout OEMs for knowhow and to penetrate USA…
Sincerely hope they ramp up domestic operations, exports and then OEMs (supplies) in the same order as indicated in management Q&A…
There has been no comment on Q2 results. It seems EPS of 18 will be very much possible. After having gone through the ARs and the management interviews, I agree that it can do very well in next 2-3 years. I have not digged into Shilpa but which one looks more undervalued at CMP? Polymed has corrected a bit and now trading near 150 DMA with low volumes.
The Commercial Court no. 4 ofBarcelonahas prohibited the manufacture and/or import inSpainof safety IV catheters supplied by Poly Medicure, Ltd. (Polymed) while B. Braun’s Spanish patent ES2402727 (EP1911487) remains in force.
The case was initiated lastNovember 2013, when B. Braun became aware that a Spanish company took part in a public tender called by the health authorities of Basque Country (Osakidetza), with an offer of safety IV catheters supplied by Polymed and commercialised inEuropeby the German company Troge Medical GmbH which fell under the scope of said patent.
great work…im new to this forum…i wish to know how u got hold of this news about the court verdict…i googled on polymed as search but could not get…
it would be really nice of u to guide people like us on how to get news about companies…any spl website(for pharma especially)…to know about fds approvals etc etc…to keep track when matter comes for hearing/verdict fr approvals etc…
you can search the company name in “Google News” and track latest updates from the companies.
Alternatively, I set up Google Alerts for all my portfolio companies where any updates/news across the world triggers an email right to your inbox. Here you won’t miss critical updates.
